Jefferies Group LLC Biotechnology

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Stock List

Stock Option Type Value Options Held Last Trade Trade History
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$18.7 Million
93.6K
Q3 2022
Added 176.57%
SAVA
Cassava Sciences Inc
PUT
$16.9 Million
403K
Q3 2022
Reduced 41.16%
SRPT
Sarepta Therapeutics, Inc.
PUT
$12.7 Million
115K
Q3 2022
Reduced 33.47%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$11 Million
54.8K
Q3 2022
Added 176.57%
SRPT
Sarepta Therapeutics, Inc.
CALL
$7.24 Million
65.5K
Q3 2022
Reduced 33.47%
SAVA
Cassava Sciences Inc
CALL
$6.87 Million
164K
Q3 2022
Reduced 41.16%
CLDX
Celldex Therapeutics, Inc.
CALL
$3.59 Million
128K
Q2 2022
Added 1144.17%
QURE
Uni Qure N.V.
CALL
$2.85 Million
152K
Q3 2022
Added 1936.02%
SGEN
Seagen Inc.
CALL
$2.74 Million
20K
Q3 2022
Reduced 72.73%
MRTX
Mirati Therapeutics, Inc.
PUT
$2.56 Million
36.6K
Q3 2022
Added 114.44%
RCKT
Rocket Pharmaceuticals, Inc.
CALL
$1.6 Million
100K
Q3 2022
Added 2249900.0%
NVAX
Novavax Inc
CALL
$1.54 Million
84.6K
Q3 2022
Reduced 94.35%
VRTX
Vertex Pharmaceuticals Inc
CALL
$1.51 Million
5.2K
Q3 2022
Added 29.66%
SAGE
Sage Therapeutics, Inc.
CALL
$1.48 Million
37.8K
Q2 2022
Added 105.56%
EDIT
Editas Medicine, Inc.
PUT
$1.41 Million
116K
Q3 2022
Added 116.49%
TCDA
Tricida, Inc.
CALL
$1.3 Million
124K
Q3 2022
New holding
AKRO
Akero Therapeutics, Inc.
PUT
$1.02 Million
30K
Q3 2022
New holding
QURE
Uni Qure N.V.
PUT
$855,000
45.6K
Q3 2022
Added 1936.02%
VRNA
Verona Pharma PLC
CALL
$766,000
75K N/A
AMLX
Amylyx Pharmaceuticals, Inc.
PUT
$758,000
27.2K
Q3 2022
New holding
INCY
Incyte Corp
CALL
$726,000
10.9K
Q3 2022
Added 15.61%
KALV
Kal Vista Pharmaceuticals, Inc.
CALL
$725,000
50K
Q3 2022
New holding
ISEE
Iveric Bio, Inc.
CALL
$717,000
40K
Q3 2022
Added 2860.55%
NTLA
Intellia Therapeutics, Inc.
PUT
$699,000
12.5K
Q3 2022
Added 7.78%
OMER
Omeros Corp
PUT
$698,000
222K
Q2 2018
Closed
EDIT
Editas Medicine, Inc.
CALL
$673,000
55K
Q3 2022
Added 116.49%
FENC
Fennec Pharmaceuticals Inc.
PUT
$656,000
83.8K
Q3 2022
New holding
SWTX
Spring Works Therapeutics, Inc.
CALL
$641,000
22.5K
Q3 2022
Added 3.08%
AMLX
Amylyx Pharmaceuticals, Inc.
CALL
$618,000
22.2K
Q3 2022
New holding
ABCL
Ab Cellera Biologics Inc.
CALL
$543,000
55K
Q3 2022
Reduced 80.73%
AVXL
Anavex Life Sciences Corp.
PUT
$516,000
50K
Q2 2022
Reduced 86.09%
TCDA
Tricida, Inc.
PUT
$487,000
46.5K
Q3 2022
New holding
FGEN
Fibrogen Inc
CALL
$455,000
35K
Q2 2021
Added 1383.54%
CLDX
Celldex Therapeutics, Inc.
PUT
$449,000
16K
Q2 2022
Added 1144.17%
VERV
Verve Therapeutics, Inc.
PUT
$415,000
12.1K
Q3 2022
New holding
NVAX
Novavax Inc
PUT
$407,000
22.4K
Q3 2022
Reduced 94.35%
IMRA
Imara Inc.
PUT
$381,000
170K
Q3 2022
New holding
VERU
Veru Inc.
PUT
$376,000
32.7K
Q1 2020
New holding
PRTA
Prothena Corp Public LTD CO
CALL
$303,000
5K
Q3 2022
New holding
DICE
Dice Therapeutics, Inc.
CALL
$263,000
13K N/A
LQDA
Liquidia Corp
PUT
$256,000
47.2K
Q3 2022
New holding
LQDA
Liquidia Corp
CALL
$256,000
47.2K
Q3 2022
New holding
ALDX
Aldeyra Therapeutics, Inc.
PUT
$186,000
35K
Q3 2022
Reduced 98.66%
PRTA
Prothena Corp Public LTD CO
PUT
$181,000
3K
Q3 2022
New holding
CDXS
Codexis, Inc.
CALL
$156,000
25.8K
Q3 2022
Added 6.28%
IMUX
Immunic, Inc.
PUT
$137,000
42.8K
Q3 2022
New holding
CDXS
Codexis, Inc.
PUT
$121,000
20K
Q3 2022
Added 6.28%
VERV
Verve Therapeutics, Inc.
CALL
$99,000
2.9K
Q3 2022
New holding
FENC
Fennec Pharmaceuticals Inc.
CALL
$78,000
10K
Q3 2022
New holding
Filter Shares Options
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email